Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in Arizona

445 recruiting clinical trials across 15 cities in Arizona (AZ). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
445
Total Trials
445
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in Arizona

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT00196742

Fabry Disease Registry & Pregnancy Sub-registry

The Fabry Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Fabry disease,...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 900020 locations
Fabry Disease
RECRUITINGNCT00231400

Pompe Disease Registry Protocol

The Pompe Registry is a global, multicenter, international, longitudinal, observational, and voluntary program for patients with Pompe disease, designed to track the disease's...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 200020 locations
Glycogen Storage Disease Type IIPompe Disease
RECRUITINGNCT00358943

International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease,...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 1200020 locations
Gaucher DiseaseCerebroside Lipidosis SyndromeGlucocerebrosidase Deficiency Disease+1
RECRUITINGNCT00567073

Pompe Pregnancy Sub-Registry

This Sub-registry is a multicenter, international, longitudinal, observational, and voluntary program designed to track pregnancy outcomes for any pregnant woman enrolled in the...

Sponsor: Genzyme, a Sanofi CompanyEnrolling: 2020 locations
Glycogen Storage Disease Type II (GSD-II)Pompe Disease (Late-onset)Glycogenesis 2 Acid Maltase Deficiency
RECRUITINGPhase 2NCT00739362

Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

This study will determine whether electrical stimulation of an area of the brain called the dorsolateral prefrontal cortex, which is important in determining the feeling of...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 1481 location
Electric Stimulation TherapyObesityWeight Loss+1
RECRUITINGNCT01524276

Product Surveillance Registry

The purpose of the Registry is to provide continuing evaluation and periodic reporting of safety and effectiveness of Medtronic market-released products. The Registry data is...

Sponsor: MedtronicEnrolling: 10000020 locations
Cardiac Rhythm DisordersUrological DisordersNeurological Disorders+13
RECRUITINGNCT01574053

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT in North America and...

Sponsor: CHDI Foundation, Inc.Enrolling: 3500020 locations
Huntington's Disease
RECRUITINGNCT01915511

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

The Idiopathic Pulmonary Fibrosis Prospective Outcomes (IPF-PRO) Registry started recruiting in 2014 with the objective of studying Idiopathic Pulmonary Fibrosis. In 2018, the...

Sponsor: Duke UniversityEnrolling: 300020 locations
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
RECRUITINGNCT02135705

LOWER: Lomitapide Observational Worldwide Evaluation Registry

This global product exposure registry is a multicentre, long-term, prospective, observational cohort study (exposure registry), designed to evaluate the long term safety and...

Sponsor: Amryt PharmaEnrolling: 30020 locations
Homozygous Familial Hypercholesterolemia
RECRUITINGPhase 2 / Phase 3NCT02205762

LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age \< 18 years).

Sponsor: North American Consortium for HistiocytosisEnrolling: 140020 locations
Langerhans Cell Histiocytosis
RECRUITINGPhase 1 / Phase 2NCT02343042

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of...

Sponsor: Karyopharm Therapeutics INCEnrolling: 30020 locations
Multiple Myeloma
RECRUITINGNCT02402244

Project: Every Child for Younger Patients With Cancer

This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may...

Sponsor: Children's Oncology GroupEnrolling: 7500020 locations
Adrenal Gland PheochromocytomaCarcinoma In SituCentral Nervous System Neoplasm+15
RECRUITINGNCT02815891

A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across...

TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice....

Sponsor: Target PharmaSolutions, INC.Enrolling: 1500020 locations
Nonalcoholic Fatty LiverNonalcoholic Steatohepatitis
RECRUITINGPhase 3NCT02901184

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Cardiac Function Heart...

Sponsor: Uppsala UniversityEnrolling: 200020 locations
Heart Failure With Preserved Ejection Fraction
RECRUITINGPhase 4NCT02915198

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

This research will help us to learn if the medicine called metformin reduces the risk of death, heart attacks, and/or strokes in Veterans who have pre-diabetes and heart or blood...

Sponsor: VA Office of Research and DevelopmentEnrolling: 741020 locations
Prediabetic StateAtherosclerosisMetformin
RECRUITINGNCT03003299

PARTNER 3 Trial - Aortic Valve-in-Valve

This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.

Sponsor: Edwards LifesciencesEnrolling: 12520 locations
Aortic StenosisAortic Stenosis, Severe
RECRUITINGPhase 3NCT03016819

Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma...

THIS STUDY IS CURRENTLY RECRUITING PATIENTS WITH ALVEOLAR SOFT PART SARCOMA ONLY AND IS NO LONGER RECRUITING PATIENTS WITH SYNOVIAL SARCOMA OR LEIOMYOSARCOMA. This study...

Sponsor: Advenchen Laboratories, LLCEnrolling: 32520 locations
Alveolar Soft Part SarcomaLeiomyosarcomaSynovial Sarcoma+1
RECRUITINGPhase 1NCT03017820

A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in...

This phase I trial studies the best dose and side effects of the VSV-hIFNβ-NIS vaccine with or without cyclophosphamide and combinations of ipilimumab, nivolumab, and cemiplimab...

Sponsor: Mayo ClinicEnrolling: 1272 locations
B-Cell Non-Hodgkin LymphomaHistiocytic and Dendritic Cell NeoplasmMyelodysplastic Syndrome+16
RECRUITINGNCT03142152

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

The objective of this prospective, randomized, blinded clinical trial is to assess the safety and efficacy of the Carillon Mitral Contour System in treating heart failure with...

Sponsor: Cardiac Dimensions, Inc.Enrolling: 30020 locations
Functional Mitral RegurgitationHeart FailureMitral Valve Insufficiency+3
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGPhase 3NCT03401398

Stress Hydrocortisone In Pediatric Septic Shock

SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive...

Sponsor: Jerry ZimmermanEnrolling: 50020 locations
Septic Shock
RECRUITINGNCT03452774

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool,...

Sponsor: Massive Bio, Inc.Enrolling: 5000020 locations
Cancer, MetastaticCancerCancer of Pancreas+40
RECRUITINGPhase 1NCT03460977

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and...

The purpose of this study is to learn about the safety and effects of the study medicine (called Mevrometostat) for the possible treatment of Relapsed/ Refractory Small Cell Lung...

Sponsor: PfizerEnrolling: 45320 locations
Metastatic Castration Resistant Prostate Cancer (mCRPC)Small Cell Lung Cancer (SCLC)Follicular Lymphoma (FL)
RECRUITINGNCT03481829

Early Tracking of Childhood Health Determinants (ETCHED) Study

Background: Children s weight has increased sharply in recent years. This may put them at higher risk for health problems. High blood glucose in a pregnant mother and too much...

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Enrolling: 15001 location
Diabetes MellitusObesityFatty Liver
RECRUITINGPhase 3NCT03488693

Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer

The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation...

Sponsor: Canadian Cancer Trials GroupEnrolling: 214020 locations
Breast Cancer
RECRUITINGNCT03507257

Longitudinal Early-onset Alzheimer's Disease Study Protocol

The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) is a non-randomized, natural history, non-treatment study designed to look at disease progression in individuals...

Sponsor: Indiana UniversityEnrolling: 85020 locations
Early Onset Alzheimer DiseaseAlzheimer DiseaseMild Cognitive Impairment
RECRUITINGPhase 3NCT03550391

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or...

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of...

Sponsor: Canadian Cancer Trials GroupEnrolling: 20620 locations
Brain Metastases
RECRUITINGPhase 3NCT03592472

A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma...

This is a randomized, Phase 3, double-blind, placebo-controlled study of pazopanib plus abexinostat versus pazopanib plus placebo in patients with locally advanced unresectable or...

Sponsor: Xynomic Pharmaceuticals, INC.Enrolling: 41320 locations
Renal Cell Carcinoma
RECRUITINGPhase 3NCT03683251

Extension Study for the Port Delivery System With Ranibizumab (Portal)

This study will evaluate the long-term safety and tolerability of the Port Delivery System with ranibizumab (PDS) (100 mg/mL) in participants with neovascular age-related macular...

Sponsor: Hoffmann-La RocheEnrolling: 100020 locations
Neovascular Age-Related Macular Degeneration
RECRUITINGPhase 2NCT03739814

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent,...

This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic...

Sponsor: National Cancer Institute (NCI)Enrolling: 8420 locations
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeRecurrent B Acute Lymphoblastic LeukemiaRefractory B Acute Lymphoblastic Leukemia

Showing 30 of 445 trials in Arizona. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 445 clinical trials actively recruiting participants in Arizona. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in Arizona include Alzheimer Disease, Non Small Cell Lung Cancer, Obesity, Heart Failure, Migraine. Each has multiple active trials across research centers in the state.

Major trial sites in Arizona include Phoenix, Tucson, Scottsdale, Gilbert, Chandler. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.